Latest market price
5.78
-0.53-8.40%
News
Down 8.4% — Anteris Reports Medium-Size DurAVR THV Outcomes from the EMBARK Study at TCT 2026 (globenewswire.com).
Medium confidence
TA
Loading chart...
Snapshot
| Index | — | P/E | — | EPS (ttm) | -2.76 | Insider Own | 19.41% | Shs Outstand | 97.46M | Perf Week | 0.00% |
| Market Cap | 563.31M | Forward P/E | — | EPS next Y | -1.22 | Insider Trans | -7.88% | Shs Float | 65.99M | Perf Month | -25.03% |
| Enterprise Value | 309.31M | PEG | — | EPS next Q | -0.31 | Short Float | 12.02% | Perf Quarter | -30.19% | ||
| Income | -103.00M | P/S | — | EPS this Y | — | Short Ratio | 8.42 | Perf Half Y | -5.71% | ||
| Sales | 1.00M | P/B | 2.24 | EPS next Y | — | ROA | -38.01% | Short Interest | 7.93M | Perf YTD | 15.83% |
| Book/sh | 2.59 | P/C | 2.19 | EPS next 5Y | — | ROE | -77.66% | 52W High | 11.06 -47.74% | Perf Year | 34.11% |
| Cash/sh | 2.64 | P/FCF | — | EPS past 3/5Y | — | ROIC | -41.63% | 52W Low | 3.30 75.15% | Perf 3Y | — |
| Dividend Est. | — | EV/EBITDA | — | Sales past 3/5Y | -12.64% -16.74% | Gross Margin | 36.98% | Volatility | 8.21% 5.55% | Perf 5Y | — |
| Dividend TTM | — | EV/Sales | — | EPS Y/Y TTM | — | Oper. Margin | -4738.36% | ATR (14) | 0.39 | Perf 10Y | — |
| Dividend Ex-Date | — | Quick Ratio | 14.20 | Sales Y/Y TTM | -75.00% | Profit Margin | -4619.67% | RSI (14) | 33.30 | Recom | 2.00 |
| Dividend Gr. 3/5Y | — | Current Ratio | 14.20 | EPS Q/Q | 48.28% | SMA20 | -8.09% | Beta | 1.40 | Target Price | 10.00 |
| Payout | 0.00% | Debt/Eq | 0.01 | Sales Q/Q | 0.00% | SMA50 | -22.84% | Rel Volume | 3.68 | Prev Close | 6.31 |
| Employees | 174 | LT Debt/Eq | 0.01 | Earnings | Nov 11 | SMA200 | -21.83% | Avg Volume | 1.09M | Price | 5.78 |
| IPO Date | Dec 13, 2024 | Option/Short | Yes / Yes | EPS/Sales Surpr. | -44.72% -32.73% | Net Debt/EBITDA | — | Volume | 4,017,767 | Change | -8.40% |
Analyst Ratings
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Oct-06-26 | Initiated | Barclays | Equal Weight | $18 → $10 |
| May-15-26 | Reiterated | Barclays | Overweight | $18 |
| Jan-23-26 | Reiterated | Lake Street | $20 → $15 | |
| Jan-07-25 | Initiated | Cantor Fitzgerald | Overweight | $9.00 |
Latest News· Times ET
Nov-01-26
Nov-01-2602:59PM
Oct-27-26
Oct-27-2606:00AM
Oct-19-26
Oct-19-2610:21PM
Anteris Technologies secures German clearance to expand PARADIGM heart valve trialproactiveinvestors.com
09:12PM
Oct-14-26
Oct-14-2602:47AM
Oct-11-26
Oct-11-2605:38AM
Oct-07-26
Oct-06-26
Oct-06-2607:09AM
07:09AM
Sep-06-26
Sep-01-26
Sep-01-2604:11AM
Aug-31-26
Aug-26-26
Aug-26-2604:43AM
Aug-14-26
Aug-14-2602:37AM
Company
Anteris Technologies Global Corp. is a structural heart innovator dedicated to discovering, developing, and bringing to market medical devices that enhance the well-being of patients grappling with aortic stenosis. The company's premier offering is the DurAVR transcatheter heart valve system, a pioneering transcatheter aortic valve engineered to treat aortic stenosis by precisely emulating the performance of a healthy human aortic valve. Beyond this, Anteris develops ADAPT anti-calcification tissue, a unique preparation that transforms xenograft tissue into robust bioscaffolds. These bioscaffolds are designed to simulate human tissue for various surgical repairs, notably in aortic valve replacement. Additionally, the ComASUR delivery system, a physician-designed balloon-expandable apparatus, features a reinforced, steerable catheter. This allows for highly accurate navigation through cardiac anatomy in a controlled manner, thereby mitigating potential damage to the aorta. Founded in 1999, Anteris Technologies Global Corp. operates out of Toowong, Australia.
Ownership
Per-holder 13F data hasn't been ingested for this ticker yet.
Financial Statements
DataTimeframe
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1 | 2 | 3 | 3 | — | — | — | |
| Cost of Goods Sold Incl. D&A | 2 | 2 | 1 | 2 | — | — | — | |
| Gross Profit | 1 | 0 | 1 | 1 | — | — | — | |
| Selling, General and Administrative Excl. Other | 24 | 24 | 0 | 17 | — | — | — | |
| Research and Development | 77 | 69 | 51 | 31 | — | — | — | |
| Other Operating Expense | 7 | 1 | 29 | 1 | — | — | — | |
| Operating Income | -106 | -94 | -78 | -48 | — | — | — | |
| Interest Expense | 0 | 0 | 0 | 0 | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 4 | 0 | 2 | 1 | — | — | — | |
| Net Income Before Taxes | -102 | -94 | -76 | -47 | — | — | — | |
| Income Taxes | 0 | 0 | 0 | 0 | — | — | — | |
| Consolidated Net Income | -103 | -94 | -76 | -46 | — | — | — | |
| Net Income From Continuing Operations | -103 | -94 | -76 | -47 | — | — | — | |
| Net Income | -103 | -94 | -76 | -46 | — | — | — | |
| EPS (Recurring) | -2.76 | -2.55 | -3.77 | -1.28 | — | — | — | |
| EPS (Basic, Before Extraordinaries) | -2.76 | -2.55 | -3.77 | -1.28 | — | — | — | |
| EPS (Diluted) | -2.76 | -2.55 | -3.77 | -1.28 | — | — | — | |
| EBITDA | -101 | -92 | -74 | -46 | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | — | — | — | — | — | — | — | |
| Price To Sales Ratio | 560.66 | 92.32 | 37.20 | — | — | — | — | |
| Gross Margin | 100.00 | 0.00 | 33.33 | 33.33 | — | — | — | |
| Operating Margin | -10,600.00 | -4,700.00 | -2,600.00 | -1,600.00 | — | — | — | |
| Net Margin | -10,300.00 | -4,700.00 | -2,533.33 | -1,533.33 | — | — | — | |
| Shares Outstanding | 97 | 37 | 20 | 36 | — | — | — | |
| Market Capitalization | 561 | 185 | 112 | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — |
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
Insider Trading
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| L1 Capital Pty Ltd | 10% Owner | Oct 06 '26 | Buy | 7.18 | 272,695 | 1,957,950 | 6,358,271 | Oct 08 |
| L1 Capital Pty Ltd | 10% Owner | Oct 05 '26 | Buy | 7.51 | 648,455 | 4,869,897 | 12,778,380 | Oct 06 |
| L1 Capital Pty Ltd | 10% Owner | Oct 02 '26 | Buy | 7.78 | 236,354 | 1,838,834 | 12,129,925 | Oct 06 |
| L1 Capital Pty Ltd | 10% Owner | Oct 01 '26 | Buy | 7.60 | 322,940 | 2,454,344 | 5,200,767 | Oct 01 |
| L1 Capital Pty Ltd | 10% Owner | Sep 30 '26 | Buy | 7.72 | 74,286 | 573,488 | 4,877,827 | Oct 01 |
| L1 Capital Pty Ltd | 10% Owner | Aug 28 '26 | Sale | 8.83 | 7,800 | 68,874 | 4,803,541 | Sep 01 |
| St Denis David | Chief Operating Officer | Aug 19 '26 | Option Exercise | 5.65 | 60,000 | 339,000 | 161,082 | Aug 20 |
| L1 Capital Pty Ltd | 10% Owner | Aug 11 '26 | Sale | 9.30 | 375,815 | 3,495,080 | 4,811,341 | Aug 12 |
| L1 Capital Pty Ltd | 10% Owner | Aug 10 '26 | Sale | 9.10 | 251,844 | 2,291,780 | 5,187,156 | Aug 12 |
| L1 Capital Pty Ltd | 10% Owner | Aug 06 '26 | Sale | 8.10 | 174,721 | 1,415,240 | 5,439,000 | Aug 10 |
| L1 Capital Pty Ltd | 10% Owner | Aug 05 '26 | Sale | 8.23 | 14,581 | 120,002 | 5,613,721 | Aug 06 |
| L1 Capital Pty Ltd | 10% Owner | Aug 04 '26 | Sale | 8.30 | 480,608 | 3,989,046 | 5,628,302 | Aug 06 |
| L1 Capital Pty Ltd | 10% Owner | Aug 03 '26 | Sale | 8.10 | 475,693 | 3,853,113 | 6,108,910 | Aug 04 |
| L1 Capital Pty Ltd | 10% Owner | Jul 31 '26 | Sale | 8.15 | 48,711 | 396,995 | 6,584,603 | Aug 04 |
| L1 Capital Pty Ltd | 10% Owner | Jul 30 '26 | Sale | 8.20 | 558,633 | 4,580,791 | 6,633,314 | Jul 31 |
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.